Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v1-EN
Language French English
Date Updated 2021-09-02 2021-09-02
Drug Identification Number 02443368 02443368
Brand name TOBRAMYCIN INHALATION SOLUTION TOBRAMYCIN INHALATION SOLUTION
Common or Proper name TOBRAMYCIN INH TOBRAMYCIN INH
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients TOBRAMYCIN TOBRAMYCIN
Strength(s) 300MG 300MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 56 LIIN 56 LIIN
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-08-31 2021-08-31
Remaining supply date 2021-08-31 2021-08-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments